Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/12377
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMaple-Brown, Louise Jen
dc.contributor.authorHughes, Jaquelyne Ten
dc.contributor.authorLu, Zhong Xen
dc.contributor.authorJeyaraman, Kanakamanien
dc.contributor.authorLawton, Paulen
dc.contributor.authorJones, Graham Rden
dc.contributor.authorEllis, Andrewen
dc.contributor.authorSinha, Ashimen
dc.contributor.authorCass, Alanen
dc.contributor.authorMacIsaac, Richard Jen
dc.contributor.authorJerums, Georgeen
dc.contributor.authorO'Dea, Kerinen
dc.date.accessioned2015-05-16T02:04:11Z
dc.date.available2015-05-16T02:04:11Z
dc.date.issued2014-07-16en
dc.identifier.citationDiabetology & Metabolic Syndrome 2014; 6(): 78en
dc.identifier.govdoc25197323en
dc.identifier.otherPUBMEDen
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/12377en
dc.description.abstractLow levels of serum 25-hydroxy vitamin D (25(OH)D), have been associated with development of type 2 diabetes and cardiovascular disease (CVD); however there are limited data on serum 25(OH)D in Indigenous Australians, a population at high risk for both diabetes and CVD. We aimed to assess levels of serum 25(OH)D in Aboriginal and Torres Strait Islander Australians and to explore relationships between 25(OH)D and cardio-metabolic risk factors and diabetes.592 Aboriginal and/or Torres Strait Islander Australian participants of The eGFR (estimated glomerular filtration rate) Study, a cross-sectional analysis of a cohort study performed in 2007-2011, from urban and remote centres within communities, primary care and tertiary hospitals across Northern Territory, Far North Queensland and Western Australia. Assessment of serum 25(OH)D, cardio-metabolic risk factors (central obesity, diabetes, hypertension, history of cardiovascular disease, current smoker, low HDL-cholesterol), and diabetes (by history or HbA1c ≥6.5%) was performed. Associations were explored between 25(OH)D and outcome measures of diabetes and number of cardio-metabolic risk factors.The median (IQR) serum 25(OH)D was 60 (45-77) nmol/L, 31% had 25(OH)D <50 nmol/L. For participants with 25(OH)D < 50 vs ≥50 nmol/L, cardio-metabolic risk profile differed for: diabetes (54%, 36% p < 0.001), past history of cardiovascular disease (16%, 9%, p = 0.014), waist-hip ratio (0.98, 0.92, p < 0.001), urine albumin-creatinine ratio (2.7, 1.5 mg/mmol, p < 0.001). The OR (95% CI) for diabetes was 2.02 (1.03 - 3.95) for people in the lowest vs highest tertiles of 25(OH)D (<53 vs >72 nmol/L, respectively) after adjusting for known cardio-metabolic risk factors.The percentage of 25(OH)D levels <50 nmol/L was high among Aboriginal and Torres Strait Islander Australians from Northern and Central Australia. Low 25(OH)D level was associated with adverse cardio-metabolic risk profile and was independently associated with diabetes. These findings require exploration in longitudinal studies.en
dc.language.isoenen
dc.subject.other25-hydroxy vitamin Den
dc.subject.otherAboriginalen
dc.subject.otherCardiovascular risken
dc.subject.otherType 2 diabetesen
dc.titleSerum vitamin D levels, diabetes and cardio-metabolic risk factors in Aboriginal and Torres Strait Islander Australians.en
dc.typeJournal Articleen
dc.identifier.journaltitleDiabetology & metabolic syndromeen
dc.identifier.affiliationSt Vincent's Hospital, Melbourne, Australia ; University of Melbourne, Melbourne, Australiaen
dc.identifier.affiliationMenzies School of Health Research, Charles Darwin University, Darwin, Australia ; University of South Australia, Adelaide, Australiaen
dc.identifier.affiliationCairns Base Hospital and Diabetes Centre, Cairns, Australiaen
dc.identifier.affiliationAustin Health, Melbourne, Australia ; University of Melbourne, Melbourne, Australiaen
dc.identifier.affiliationSydPath, St Vincents Hospital, Sydney, Australia ; University of NSW, Sydney, Australiaen
dc.identifier.affiliationMenzies School of Health Research, Charles Darwin University, Darwin, Australiaen
dc.identifier.affiliationUniversity of South Australia, Adelaide, Australiaen
dc.identifier.affiliationMelbourne Pathology, Melbourne, Australia ; Department of Medicine, Monash University, Melbourne, Australiaen
dc.identifier.affiliationMenzies School of Health Research, Charles Darwin University, Darwin, Australia ; Division of Medicine, Royal Darwin Hospital, Darwin, Australiaen
dc.identifier.doi10.1186/1758-5996-6-78en
dc.description.pages78en
dc.relation.urlhttps://pubmed.ncbi.nlm.nih.gov/25197323en
dc.type.austinJournal Articleen
local.name.researcherJerums, George
item.grantfulltextopen-
item.openairetypeJournal Article-
item.fulltextWith Fulltext-
item.languageiso639-1en-
item.cerifentitytypePublications-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
crisitem.author.deptEndocrinology-
Appears in Collections:Journal articles
Files in This Item:
File Description SizeFormat 
25197323.pdf247.47 kBAdobe PDFThumbnail
View/Open
Show simple item record

Page view(s)

30
checked on Oct 18, 2024

Download(s)

96
checked on Oct 18, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.